Namrata Khurana

Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer

Namrata Khurana, Hogyoung Kim, Partha K. Chandra et al. · Oncology Reports · 2017 · 49 citations · Full text

Chemoprevention Strategy, Pharmacotherapy, Cancer Biology +18

Differential expression of novel biomarkers (TLR-2, TLR-4, COX-2, and Nrf-2) of inflammation and oxidative stress in semen of leukocytospermia patients

Suzanne Hagan, Namrata Khurana, Surabhi Chandra et al. · Andrology · 2015 · 42 citations · Full text

Immunology, Reproductive Health, Pathology +23

IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer

Qiong Li, Yali Chen, Daoxiang Zhang et al. · JCI Insight · 2019 · 40 citations · Full text

Sulforaphane increases the efficacy of anti-androgens by rapidly decreasing androgen receptor levels in prostate cancer cells

Namrata Khurana, Sudha Talwar, Partha K. Chandra et al. · International Journal of Oncology · 2016 · 31 citations · Full text

Ar Gene Expression, Urology, Oncology +10

TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations

Paarth B. Dodhiawala, Namrata Khurana, Daoxiang Zhang et al. · Journal of Clinical Investigation · 2020 · 30 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +22